在T细胞淋巴瘤的进展和中枢神经系统参与的危险因素
Omar Elghawy1, Nishwant Swami1, Zachary A Hing1
1Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Leukemia & lymphoma
|July 1, 2025
概括
T细胞淋巴瘤 (TCL) 是一种罕见的癌症,治疗反应不佳. 本综述涵盖TCL流行病学,中枢神经系统 (CNS) 复发的危险因素,以及像免疫疗法这样的新兴疗法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- T细胞淋巴瘤 (TCL) 是一种罕见的,异质的血液性瘤.
- 这些癌症往往对常规化疗反应不佳,缺乏黄金标准治疗.
- 中枢神经系统 (CNS) 参与TCL是罕见的,但与预后不佳和增加的发病率有关.
研究的目的:
- 审查主要和复发性T细胞淋巴瘤的流行病学,危险因素和治疗.
- 探索TCL的治疗策略,包括中枢神经系统参与和不参与的治疗策略.
- 讨论新的治疗方法,如表观遗传调节,CAR T细胞疗法和免疫疗法.
主要方法:
- 关于T细胞淋巴瘤流行病学的文献综述.
- 对TCL中中枢神经系统复发的风险因素的分析.
- 目前和新兴的TCL治疗模式的摘要.
主要成果:
- TCLs是罕见的,并且难以用标准化疗治疗.
- 中枢神经系统在TCL的复发不常见,但显著恶化了结果.
- 包括免疫疗法在内的新的治疗途径显示出有前途.
结论:
- 了解TCL流行病学和风险因素对于患者管理至关重要.
- 像表观遗传调节,CAR T细胞疗法和免疫疗法这样的新疗法为TCL治疗提供了新的希望.
- 需要进一步的研究来建立TCL的最佳治疗方案,特别是涉及中枢神经系统.
相关概念视频
01:18Lymphoid Cells and Tissues
1.6K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.6K
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667